This study is testing a new HIV vaccine on adults without HIV. The vaccine uses special proteins and virus particles to help the body make antibodies. Antibodies are proteins that help fight infections. This study aims to see if the vaccine is safe and if it helps the body make these antibodies.
Participants must be adults aged 18 to 55 and in good health. They cannot be pregnant or have certain health conditions. Participants will have regular clinic visits to receive the vaccine and must fill out a daily symptom diary.
- Study Duration: Participants will be involved through several clinic visits over a period.
- Eligibility: Must be 18-55 years old and in good health.
- Commitments: Regular clinic visits and symptom tracking.
Before joining, potential participants will have to understand the study and agree not to join another clinical trial. They must also use effective birth control during the study. The study excludes people with certain health conditions like severe asthma or recent vaccines. If interested, please ensure you meet all eligibility criteria and are willing to follow study procedures.